Cargando…

ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer

In patients with metastatic colon cancer, response to first line chemotherapy is a strong predictor of overall survival (OS). Currently, oncologists lack diagnostic tests to determine which chemotherapy regimen offers the greatest chance for response in an individual patient. Here we present the res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choueiri, Michel B., Shen, John Paul, Gross, Andrew M., Huang, Justin K., Ideker, Trey, Fanta, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470586/ https://www.ncbi.nlm.nih.gov/pubmed/26083491 http://dx.doi.org/10.1371/journal.pone.0126898

Ejemplares similares

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
por: Krawczyk, Paweł, et al.
Publicado: (2014)

ERCC1、RRM1和TS在非小细胞肺癌中的临床意义
Publicado: (2014)

Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types
por: Gross, Andrew M., et al.
Publicado: (2015)

Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells
por: Kapoor, Sabeeta, et al.
Publicado: (2021)

Network-based stratification of tumor mutations
por: Hofree, Matan, et al.
Publicado: (2013)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?
por: Gao, Rui, et al.
Publicado: (2013)

Polymorphisms of GSTP1, ERCC2 and TS-3′UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients
por: KUMAMOTO, KENSUKE, et al.
Publicado: (2013)

Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review
por: Wang, Zhen, et al.
Publicado: (2012)

Genome-Wide Fitness and Expression Profiling Implicate Mga2 in Adaptation to Hydrogen Peroxide
por: Kelley, Ryan, et al.
Publicado: (2009)

Typing tumors using pathways selected by somatic evolution
por: Wang, Sheng, et al.
Publicado: (2018)

Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population
por: Liu, Dabiao, et al.
Publicado: (2018)

Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma
por: Sonpavde, G, et al.
Publicado: (2012)

ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy
por: Li, P, et al.
Publicado: (2013)

Is ERCC1 a prognostic biomarker for urothelial cancer following radical cystectomy? A long-term analysis
por: Obarzanowski, Mateusz, et al.
Publicado: (2021)

Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer
por: Shen, Jie, et al.
Publicado: (2014)

Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil
por: Han, Jae Joon, et al.
Publicado: (2014)

Protein Networks as Logic Functions in Development and Cancer
por: Dutkowski, Janusz, et al.
Publicado: (2011)

Network approaches and applications in biology
por: Ideker, Trey, et al.
Publicado: (2017)

The great hairball gambit
por: Flint, Jonathan, et al.
Publicado: (2019)

Circulating exosomal tsRNAs: Potential biomarkers for large artery atherosclerotic stroke superior to plasma tsRNAs
por: Yang, Kaiying, et al.
Publicado: (2023)

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
por: Tiseo, M, et al.
Publicado: (2013)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
por: Chen, Jing, et al.
Publicado: (2021)

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss
por: Gross, Andrew M, et al.
Publicado: (2014)

ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
por: Vaezi, Alec, et al.
Publicado: (2011)

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy
por: Li, Sheng, et al.
Publicado: (2014)

ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Baek, Moo-Jun
Publicado: (2015)

ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy
por: Baiomy, Mohamed Ali EL, et al.
Publicado: (2017)

ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy
por: Ryu, Hyewon, et al.
Publicado: (2017)

Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer
por: GÓMEZ-DÍAZ, BENJAMÍN, et al.
Publicado: (2015)

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

Differential network biology
por: Ideker, Trey, et al.
Publicado: (2012)

Differential analysis of high-throughput quantitative genetic interaction data
por: Bean, Gordon J, et al.
Publicado: (2012)

Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
por: Matuszczak, Milena, et al.
Publicado: (2020)

tsRBase: a comprehensive database for expression and function of tsRNAs in multiple species
por: Zuo, Yuanli, et al.
Publicado: (2020)

The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development
por: Rouissi, Kamel, et al.
Publicado: (2011)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma
por: Cui, Qing-ke, et al.
Publicado: (2014)

Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
por: Baba, H, et al.
Publicado: (2012)

ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis
por: Strippoli, Antonia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hu3512n2b542sfntdlcmi68md7